Vaccine Design and Testing – News and Features

SARS-CoV-2 was detected in six common backyard species, with evidence of human-to-animal transmission also present.

Vanderbilt researchers have developed a set of nanoparticles that stimulate the immune system in mice to fight cancer and may eventually do the same in humans.

Researchers have uncovered surprising strategies for how dengue and hundreds of other viruses replicate in their hosts. These findings offer new hope in the search for novel antiviral treatments and vaccines against dengue viral infections.

Researchers from the University of Liverpool’s Centre for Drug Safety Science have identified unpredicted T-cell immune responses to the adenoviral (Oxford/AstraZeneca and Janssen) COVID-19 vaccines.

New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine – a so-called “one and done” vaccine that confers lifetime immunity against an evolving virus.

Maternal Zika virus infections can reprogram fetal immune development, leading to long-term consequences in children’s immunity, a new study has shown.

An “unconventional” immune response recently identified by scientists is a potential new pathway for developing new vaccines for tuberculosis.

Using a novel imaging technique, researchers have described how a parasite “kisses” the surface of host cells before infection and how this affects host cell metabolism.

A breakthrough for biomedical research promises new insight into immunotherapy development and disease modeling.

Combining a pathogen's genomic DNA with human travel patterns from anonymized mobile phone data provides a new way to prevent superbug outbreaks.